Management raised fiscal 2025 EPS guidance to $7.85-$8, a $0.10 increase at the midpoint, reflecting strong Pharma performance and contributions from recent acquisitions. The company expects Q3 to be ...
Cardinal Health (CAH) reported $55.26 billion in revenue for the quarter ended December 2024, representing a year-over-year decline of 3.8%. EPS of $1.93 for the same period compares to $1.82 a year ...